Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review.

MLA

Singh, Awadhesh Kumar, and Kamlesh Khunti. “Assessment of Risk, Severity, Mortality, Glycemic Control and Antidiabetic Agents in Patients with Diabetes and COVID-19: A Narrative Review.” Diabetes Research and Clinical Practice, vol. 165, July 2020, p. 108266. EBSCOhost, https://doi.org/10.1016/j.diabres.2020.108266.

APA

Singh, A. K., & Khunti, K. (2020). Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review. Diabetes Research and Clinical Practice, 165, 108266. https://doi.org/10.1016/j.diabres.2020.108266

Chicago

Singh, Awadhesh Kumar, and Kamlesh Khunti. 2020. “Assessment of Risk, Severity, Mortality, Glycemic Control and Antidiabetic Agents in Patients with Diabetes and COVID-19: A Narrative Review.” Diabetes Research and Clinical Practice 165 (July): 108266. doi:10.1016/j.diabres.2020.108266.